XML 19 R9.htm IDEA: XBRL DOCUMENT v3.5.0.2
Share-Based Compensation
6 Months Ended
Jun. 30, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Shareholders’ Equity
Share-Based Compensation

Share-Based Compensation Expense

Share-based compensation expense recognized in the condensed consolidated statements of operations for the three and six months ended June 30, 2016 and 2015 is based on awards ultimately expected to vest.

Total share-based compensation expense related to all share-based awards for the three and six months ended June 30, 2016 and 2015 was comprised of the following (in thousands):
 
Three Months Ended 
 June 30,
 
Six Months Ended 
 June 30,
 
2016
 
2015
 
2016
 
2015
Research and development:
 
 
 
 
 
 
 
   Stock options
$
1,215

 
$
413

 
$
2,476

 
$
972

   Restricted stock

 
735

 
30

 
1,213

   Warrants
4

 
14

 
15

 
25

Research and development share-based compensation expense
1,219

 
1,162

 
2,521

 
2,210

General and administrative:
 
 
 
 
 
 
 
   Stock options
1,559

 
918

 
3,269

 
1,507

   Restricted stock
510

 
1,596

 
1,129

 
3,174

   Warrants
53

 
204

 
127

 
391

General and administrative share-based compensation expense
2,122

 
2,718

 
4,525

 
5,072

Total share-based compensation expense included in expenses
$
3,341

 
$
3,880

 
$
7,046

 
$
7,282



As of June 30, 2016, approximately $33,715,000 of total unrecognized share-based compensation expense related to non-vested stock options remains and is expected to be recognized over a weighted-average period of approximately 3.1 years. As of June 30, 2016, approximately $1,441,000 of total unrecognized share-based compensation expense related to non-vested restricted stock awards remains and is expected to be recognized over a weighted-average period of approximately 8 months.

Stock Option Valuation

The fair value of each stock option award is estimated on the grant date using a Black-Scholes option pricing model (Black-Scholes model), which uses the assumptions noted in the following table. Expected volatility is based on historical volatility of the Company’s common stock. Expected life of employee stock options is determined using the “simplified” method. The expected life of non-employee stock options is based on the contractual term of the stock options. Risk-free interest rate is based on the U.S. Treasury yield for a period consistent with the expected term of the stock options in effect at the time of the grants. Dividend yield is based on the expectation of no future dividend payments by the Company.

The Company estimated the fair value of each stock option grant on the grant date using the Black-Scholes model with the following weighted-average assumptions:
 
Six Months Ended 
 June 30,
 
2016
 
2015
Expected volatility
143
%
 
173
%
Expected life (years)
5.27 years

 
6.70 years

Risk-free interest rate
1.3
%
 
1.7
%
Dividend yield

 



Stock Options

The Company’s 2013 Equity Incentive Plan stock option activity for the six months ended June 30, 2016 is comprised of the following:
 
Outstanding Stock Options
 
Shares
Underlying
Stock Options
 
Weighted-
Average
Exercise Price
per Share
Outstanding at December 31, 2015
2,318,685

 
$
22.01

Granted
207,200

 
$
17.25

Exercised
(10,000
)
 
$
8.52

Forfeited
(46,900
)
 
$
25.75

Outstanding at June 30, 2016
2,468,985

 
$
21.59



As of June 30, 2016, there were 626,225 shares available for future grants under the 2013 Equity Incentive Plan.

Restricted Stock Awards

The Company’s restricted stock award activity for the six months ended June 30, 2016 is comprised of the following:
 
Number of
Shares
 
Weighted-
Average Grant
Date Fair
Market Value
Unvested at December 31, 2015
1,072,899

 
$
13.00

Vested
(30,220
)
 
$
5.53

Unvested at June 30, 2016
1,042,679

 
$
13.22


    
Warrants

At June 30, 2016, the Company had 68,000 warrants outstanding. During the six months ended June 30, 2016, the Company issued a warrant to purchase up to 17,000 shares of the Company’s common stock to an outside third party at a price equal to the fair market value of the Company's common stock on the grant date.